Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients
2010

Glucocorticoids and Antivirals for HBV Reactivation in Cancer Patients

Sample size: 2 publication Evidence: low

Author Information

Author(s): Marzano Alfredo MD, Marengo Andrea MD, di Fonzo Michela MD, Begini Paola MD, Ferrari Antonella MD, Monarca Bruno MD, delle Fave Gianfranco MD, Marignani Massimo MD

Primary Institution: Università Cattolica del Sacro Cuore

Hypothesis

Can glucocorticoids help manage hepatitis B reactivation in patients with onco-hematological malignancies undergoing chemotherapy?

Conclusion

The study suggests that glucocorticoids may help control immune responses in patients with HBV reactivation, but survival depends on the underlying liver condition.

Supporting Evidence

  • One patient improved after treatment with glucocorticoids and antivirals.
  • The second patient died due to liver cirrhosis that was undetected before death.

Takeaway

This study looked at two cancer patients who had hepatitis B reactivation after chemotherapy. One patient got better with treatment, but the other sadly passed away due to liver failure.

Methodology

Case reports of two patients with onco-hematological malignancies and HBV reactivation treated with glucocorticoids and antivirals.

Limitations

The study is based on only two case reports, limiting the generalizability of the findings.

Participant Demographics

Both patients were 73 years old and had different types of onco-hematological malignancies.

Digital Object Identifier (DOI)

10.4084/MJHID.2010.035

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication